Recombinant Erythropoietin Summary

Networked: 582 relevant articles (49 outcomes, 65 trials/studies) for this Bio-Agent

Key Diseases for which Recombinant Erythropoietin is Relevant

1. Anemia : 25 outcomes 28 studies in 269 results
   
2. Chronic Kidney Failure (Chronic Renal Failure) : 5 outcomes 4 studies in 97 results
   
3. Neoplasms (Cancer) : 4 outcomes 11 studies in 47 results
   
4. Myelodysplastic Syndromes (Myelodysplastic Syndrome) : 4 outcomes 3 studies in 27 results
   
5. Heart Failure : 2 outcomes 3 studies in 4 results
   

Drugs Related to Recombinant Erythropoietin

1. Hemoglobins (Hemoglobin)
2. Erythropoietin
3. Epoetin Alfa (Epogen)
4. Granulocyte Colony-Stimulating Factor (G-CSF)
5. Cisplatin (Platino)
6. Tissue Plasminogen Activator (Alteplase)
7. Cholecalciferol (Vitamin D3)
8. Cyclosporine (Ciclosporin)
9. Isotretinoin (Accutane)
10. darbepoetin alfa (Aranesp)

Therapies Related to Recombinant Erythropoietin

1. Renal Dialysis (Hemodialysis)
2. Blood Transfusion (Blood Transfusions)
3. Drug Therapy (Chemotherapy)
4. Intravitreal Injections
5. Peritoneal Dialysis